US Patent Issued to Novo Nordisk on Feb. 24 for "Donor repair templates multiplex genome editing" (Washington Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,742, issued on Feb. 24, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).

"Donor repair templates multiplex genome editing" was invented by Baeckseung Lee (Kenmore, Wash.) and Alexander Astrakhan (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides improved multiplex genome editing compositions and methods. The disclosure further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of a hemoglobinopathy, a cancer, an infectious disease, an autoimmune disease, an inflammatory disease, or an immunodeficiency."

The patent was filed on Oct. 21, 2022, under Applicatio...